City of Hope

Our guest today is Dr. Nicholas Shork.

Dr. Shork is a distinguished professor at the Translational Genomics Research Institute, also known as TGen, which is part of the City of Hope.

He is also a professor at the Arizona State University Schofield School of Medicine and Medical Engineering, the Director of Research, Longevity, and Precision Medicine at Honor Health, and also an adjunct professor at Scripps Research.

So his work spans things like human genetics, systems biology, precision medicine, and clinical study design.

Today's podcast features Dr.

Hope Rugo from the City of Hope Comprehensive Cancer Center and Dr. Niria Lupitegi-Lea from the Ohio State University Comprehensive Cancer Center.

They'll discuss key metastatic breast cancer findings presented at the 2026 ASCO Annual Meeting.

For more information on our presenters, along with a link to the full educational program, please visit the show notes for this episode.

Today on The Health Exchange, we're hearing one colorectal cancer story from both sides.

I'm Dr. Jay Rutland, and I'm joined by Amber Mike, colorectal cancer survivor and advocate, and her doctor, Dr. Krushangi Patel, oncologist and hematologist at City of Hope.

Together, they'll share what happens with diagnosis, treatment, and survivorship and how it looks.

Let's get into

But yeah, that's who I am.

And Krushagi, knowing that you're a medical oncologist and you deal with cancer patients on a daily basis, how would you describe yourself?

I am the hematologist oncologist out of City of Hope, and I really have an interest in bringing good care to the community, to where patients live.

When I think about health, I know what I think about from a clinical standpoint.